SHH and glioblastoma: SHH pathway inhibition by cyclopamine reduced clonogenicity in both GBM cell lines without affecting the metabolic turnover; it is worth noticing that MTT assay is not reflecting necessarily cell proliferation and growth, but viable cell metabolism [66].